Reexamining the evidence for inpatient glucose control: New recommendations for glycemic targets

American Journal of Health-System Pharmacy

Volumn 67, Issue 16 SUPPL. 8, 2010, Pages

  Moghissi, Etie S ^a,b  

^a American Association of Clinical Endocrinologists Inpatient Task Force   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Critical illness; Dosage schedule; Hospitals; Hyperglycemia; Insulin; Insulins; Protocols; Toxicity

Indexed keywords

CORTICOSTEROID; GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

BLOOD GLUCOSE MONITORING; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; GLYCEMIC INDEX; PRACTICE GUIDELINE; REVIEW;

BLOOD GLUCOSE; GLYCEMIC INDEX; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INPATIENTS; INSULIN; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 78149487319     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100171     Document Type: Conference Paper

References (43)

1. Rolih CA, Ober KP. The endocrine response to critical illness. Med Clin North Am. 1995; 79:211-24.
2. Garber AJ, Moghissi ES, Bransome ED Jr et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004; 10:77-82.
3. American Diabetes Association. Standards of medical care in diabetes - 2005. Diabetes Care. 2005; 28(suppl 1):S4-36.
4. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract. 2006; 12:458-68.
5. Inzucchi SE, Siegel MD. Glucose control in the ICU - how tight is too tight? N Engl J Med. 2009; 360:1346-9.
6. Centers for Disease Control and Prevention. Distribution of first-listed diagnoses among hospital discharges with diabetes as any listed diagnosis, adults age 18 years or older, United States, 2006. www.cdc.gov/diabetes/ statistics/hosp/adulttable1.htm (accessed 2009 Dec 1).
7. Wexler DJ, Nathan DM, Meigs JB et al. Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals. Diabetes Care. 2007; 30:367-9. (Pubitemid 46198347)
8. Clement S, Braithwaite SS, Magee MF et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004; 27:553-91. (Pubitemid 38174086)
9. Green Conaway DL, Enriquez JR, Barberena JE et al. Assessment of and physician response to glycemic control in diabetic patients presenting with an acute coronary syndrome. Am Heart J. 2006; 152:1022-7. (Pubitemid 44854788)
10. Norhammar A, Tenerz A, Nilsson G et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002; 359:2140-4. (Pubitemid 34694020)
11. Umpierrez GE, Isaacs SD, Bazargan N et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002; 87:978-82. (Pubitemid 36121050)
12. Centers for Disease Control and Prevention. National diabetes fact sheet, 2007. http://cdc.gov/diabetes/pubs/pdf/ndfs-2007.pdf (accessed 2010 Feb 2).
13. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008; 31:596-615.
14. Estrada CA, Young JA, Nifong LW et al. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2003; 75:1392-9. (Pubitemid 36515208)
15. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma. 2003; 55:33-8. (Pubitemid 36919233)
16. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003; 78:1471-8. (Pubitemid 37475630)
17. Furnary AP, Zerr KJ, Grunkemeier GL et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999; 67:352-60.
18. Furnary AP, Gao G, Grunkemeier GL et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003; 125:1007-21. (Pubitemid 36644877)
19. Zerr KJ, Furnary AP, Grunkemeier GL et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997; 63:356-61. (Pubitemid 27084552)
20. Pomposelli JJ, Baxter JK 3rd, Babineau TJ et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enter Nutr. 1998; 22:77-81. (Pubitemid 28117569)
21. Latham R, Lancaster AD, Covington JF et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001; 22:607-12. (Pubitemid 33152102)
22. Capes SE, Hunt D, Malmberg K et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000; 355:773-8. (Pubitemid 30128815)
23. Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004; 30:748-56. (Pubitemid 38639464)
24. Rady MY, Johnson DJ, Patel BM et al. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc. 2005; 80:1558-67. (Pubitemid 41747057)
25. Ainla T, Baburin A, Teesalu R et al. The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med. 2005; 22:1321-5. (Pubitemid 41391305)
26. McAlister FA, Majumdar SR, Blitz S et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005; 28:810-5. (Pubitemid 40434478)
27. Baker EH, Janaway CH, Philips BJ et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006; 61:284-9.
28. Falciglia M, Freyberg RW, Almenoff PL et al. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009; 37:3001-9.
29. Malmberg K, for the DIGAMI Study Group. Prospective randomised study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997; 314:1512-5.
30. Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359-67.
31. Krinsley JS. Effect of intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004; 79:992-1000. (Pubitemid 39007018)
32. Lazar HL, Chipkin SR, Fitzgerald CA et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004; 109:1497-502. (Pubitemid 38420177)
33. Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354:449-61. (Pubitemid 43200296)
34. Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006; 29:765-70. (Pubitemid 44115291)
35. Devos P, Preiser JC, Mélot C, on behalf of the Glucontrol Steering Committee. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intensive Care Med. 2007; 33:S189.
36. Preiser JC, Devos P, Ruiz-Santana S et al. A prospective randomised multicentre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009; 35:1738-48.
37. Brunkhorst FM, Engel C, Bloos F, for the German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008; 358:125-39.
38. De La Rosa GC, Donado JH, Restrepo AH et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008; 12:R120.
39. Finfer S, Chittock DR, Su SY et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009; 360:1283-97.
40. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008; 300:933-44.
41. Griesdale DE, de Souza RJ, van Dam RM et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009; 180:821-7.
42. Moghissi ES, Korytkowski MT, DiNardo M et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009; 15:353-69.
43. Moghissi ES, Korytkowski MT, DiNardo M et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009; 32:1119-31.